Advisory Committees

2015 Meeting Materials, Cellular, Tissue and Gene Therapies Advisory Committee

November 18, 2015

Joint Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee and Oncologic Drugs Advisory Committee: The committees will discuss the safety and efficacy of Biologics License Application (BLA) 125593, Mycobacterium phlei Cell wall-Nucleic Acid complex (MCNA), submitted by Telesta Therapeutics Inc.

April 29, 2015

Joint Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee and Oncologic Drugs Advisory Committee: The committees will discuss talimogene laherparepvec, Amgen, Inc., BLA 125518, an oncolytic immunotherapy for the treatment of patients with injectable regionally or distantly metastatic melanoma.

Page Last Updated: 12/18/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.